Trastuzumab: A Review of its Use in the Treatment of Metastatic Breast Cancer Overexpressing HER2

By McKeage K.   Perry C.M.  

Drugs, Vol. 62, Iss. 1, 2002-01 ,pp. : 209-243

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use in the Management of HER2-Positive Metastatic and Early-Stage Breast Cancer

By Plosker Greg L.   Keam Susan J.  

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 449-475

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

By Garnock-Jones Karly P.   Keating Gillian M.   Scott Lesley J.  

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 215-239

Adis International

Access to resources Recommend Favorite

Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2- Overexpressing Metastatic Breast Cancer

By  

Current Drug Targets, Vol. 14, Iss. 8, 2013-07 ,pp. : 889-898

Bentham Science Publishers

Access to resources Recommend Favorite

Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer

By Taskar Kunal   Rudraraju Vinay   Mittapalli Rajendar   Samala Ramakrishna   Thorsheim Helen   Lockman Julie   Gril Brunilde   Hua Emily   Palmieri Diane   Polli Joseph   Castellino Stephen   Rubin Stephen   Lockman Paul   Steeg Patricia   Smith Quentin  

Pharmaceutical Research, Vol. 29, Iss. 3, 2012-03 ,pp. : 770-781

Springer Publishing Company

Access to resources Recommend Favorite